Board Cancels Most Challenged Claims Of Molecular Profiling Patent

(May 14, 2020, 12:17 PM EDT) -- ALEXANDRIA, Va. — In a May 13 final written decision, the Patent Trial and Appeal Board deemed that 18 claims of a patented method of identifying a potential personalized medical treatment by conducting a molecular profile analysis would have been obvious to a person of skill in the art (POSA) (Foundation Medicine Inc. v. Caris MPI Inc., No. IPR2019-00166, PTAB)....

Attached Documents

Related Sections